To: Rafael Silva who wrote (5432 ) 4/24/1999 12:22:00 AM From: Chuzzlewit Read Replies (1) | Respond to of 7342
Rafael, I have lots of comments. Mainly this "analysis" is rationalization rather than real analysis. Here is what Jubak did (stripped of a lot of verbiage): 1. He said that current earnings looked clean -- they were not rigged to look better than they really were. I concur, but we will not have a complete picture until the SEC filings. 2. He estimates earnings for the year at $2.55. Perhaps this is reasonable, but it is probably not correct. Generally speaking it is impossible to have that much visibility. The company periodically meets with analysts to provide guidance as events unfold. A good portion of this guidance consists of managing earnings expectations, which means that companies try to set the bar lower rather than higher. 3. Jubak then assumes a market multiple based on trailing earnings. This is a terrible practice. Stock multiples are awarded based on several factors, not one of them being a trailing P/E -thank you very much Ben Graham (NOT). Stock are priced on the perception of future earnings growth, LT interest rates, general market conditions, and perceived risk. Hello Jubak!!! where did you discuss this stuff? Interest rates look benign. Birck announced 6B by 2003. That works out to 34% per annum (assuming 3 3/4 years to achieve the goal). And Birck has always exceeded his goals. So I think that an eps growth rate of the order of 37% is probably closer to the truth (and probably still conservative). So, let's compare that to the S&P 500 which has a long-term growth rate of around 9% and sports a market multiple of around 27x next years earnings. So, applying a CNPEG relative valuation we come up with the following: The YPEG for the S&P is around 3, and the YPEG for TLAB is 1.14, which puts the ratio to around .38. That means that the cost of growth using TLAB is 38% of the cost of growth for the S&P as a whole . 4. Finally, he takes his target price and calculates a 9 month return based on his target. That's fine if there is any validity to the target. As I hope I've shown in 3 above, I don't think there is any validity to Jubak's target. In fact, he could just as easily asked whether the current P/E is justified. Since he thinks it is not (because if it were the stock would be appreciating at a rate of at least the growth rate) he could have stopped there. But I guess the guy feels like he has to write a lot to justify his P/E <G> Rafael, Jubak's approach is appealing because it is simple, but unfortunately it is simple-minded. It is replete with assumptions that are unsupportable. One point he does make, with which I completely concur is that you need to carefully check the "quality" of earnings, and you need to look carefully at the company's SEC filings. But what do I know? TTFN, CTC